FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2313644743> ?p ?o ?g. }

• W2313644743 endingPage "497" @default.
• W2313644743 startingPage "492" @default.
• W2313644743 abstract "Background: Eosinophilic enterocolitis (EEC) is an emerging distinct inflammatory bowel disease of unknown etiology. There are no published data on the effect of infliximab (IFX) or adalimumab (ADA) for the treatment of refractory cases. Methods: A report of all pediatric cases with EEC treated with anti-tumor necrosis factor, identified after an open international call. Results: We describe here the first 8 children with refractory EEC who were treated with IFX (75% boys; mean age at diagnosis 8.6 ± 4.03 [range 1.6–14 years]; mean age at IFX treatment 11.7 ± 4.4 [range 4.2–16 years]). Allergic and infectious causes of EEC were excluded in all cases. Rapid and complete clinical remission was documented in 6 (75%) children following the induction infusions: 3 (38%) with endoscopic remission, 2 (25%) with endoscopic improvement, and 1 unknown. Four of the 6 responders had secondary loss of response and were switched to ADA, 3 of whom with sustained remission using high doses. Overall, the 6 responders were followed for a median of 7 years (range 4–12; interquartile range 6.4–8.8 years) without evidence of developing Crohn disease or ulcerative colitis. The only case with macroscopic findings on endoscopy was a primary nonresponder. Conclusions: IFX and ADA may be effective in cases of refractory idiopathic EEC; however, because this is an uncontrolled report, further prospective studies are warranted." @default.
• W2313644743 created "2016-06-24" @default.
• W2313644743 creator A5007406958 @default.
• W2313644743 creator A5035802660 @default.
• W2313644743 creator A5051962509 @default.
• W2313644743 creator A5060061551 @default.
• W2313644743 creator A5071814520 @default.
• W2313644743 creator A5079984890 @default.
• W2313644743 creator A5084520591 @default.
• W2313644743 creator A5085722944 @default.
• W2313644743 date "2013-05-01" @default.
• W2313644743 modified "2023-10-13" @default.
• W2313644743 title "Anti-TNF, Infliximab, and Adalimumab Can Be Effective in Eosinophilic Bowel Disease" @default.
• W2313644743 cites W101683208 @default.
• W2313644743 cites W1527429636 @default.
• W2313644743 cites W1967712610 @default.
• W2313644743 cites W1990259419 @default.
• W2313644743 cites W1995041568 @default.
• W2313644743 cites W1995481725 @default.
• W2313644743 cites W1996443657 @default.
• W2313644743 cites W2004093030 @default.
• W2313644743 cites W2034453465 @default.
• W2313644743 cites W2045106554 @default.
• W2313644743 cites W2064842600 @default.
• W2313644743 cites W2082256115 @default.
• W2313644743 cites W2087770516 @default.
• W2313644743 cites W2088520106 @default.
• W2313644743 cites W2093021853 @default.
• W2313644743 cites W2098392838 @default.
• W2313644743 cites W2114207745 @default.
• W2313644743 cites W2136248567 @default.
• W2313644743 cites W2137513278 @default.
• W2313644743 cites W2140974346 @default.
• W2313644743 cites W2144846148 @default.
• W2313644743 cites W2148539431 @default.
• W2313644743 cites W2159940021 @default.
• W2313644743 cites W2161132355 @default.
• W2313644743 cites W3160139121 @default.
• W2313644743 cites W4234662082 @default.
• W2313644743 cites W4241257541 @default.
• W2313644743 doi "https://doi.org/10.1097/mpg.0b013e3182801e60" @default.
• W2313644743 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23221994" @default.
• W2313644743 hasPublicationYear "2013" @default.
• W2313644743 type Work @default.
• W2313644743 sameAs 2313644743 @default.
• W2313644743 citedByCount "26" @default.
• W2313644743 countsByYear W23136447432013 @default.
• W2313644743 countsByYear W23136447432015 @default.
• W2313644743 countsByYear W23136447432016 @default.
• W2313644743 countsByYear W23136447432018 @default.
• W2313644743 countsByYear W23136447432019 @default.
• W2313644743 countsByYear W23136447432020 @default.
• W2313644743 countsByYear W23136447432021 @default.
• W2313644743 countsByYear W23136447432023 @default.
• W2313644743 crossrefType "journal-article" @default.
• W2313644743 hasAuthorship W2313644743A5007406958 @default.
• W2313644743 hasAuthorship W2313644743A5035802660 @default.
• W2313644743 hasAuthorship W2313644743A5051962509 @default.
• W2313644743 hasAuthorship W2313644743A5060061551 @default.
• W2313644743 hasAuthorship W2313644743A5071814520 @default.
• W2313644743 hasAuthorship W2313644743A5079984890 @default.
• W2313644743 hasAuthorship W2313644743A5084520591 @default.
• W2313644743 hasAuthorship W2313644743A5085722944 @default.
• W2313644743 hasBestOaLocation W23136447431 @default.
• W2313644743 hasConcept C119060515 @default.
• W2313644743 hasConcept C121332964 @default.
• W2313644743 hasConcept C126322002 @default.
• W2313644743 hasConcept C141071460 @default.
• W2313644743 hasConcept C142424586 @default.
• W2313644743 hasConcept C188816634 @default.
• W2313644743 hasConcept C2777138892 @default.
• W2313644743 hasConcept C2778260677 @default.
• W2313644743 hasConcept C2779134260 @default.
• W2313644743 hasConcept C2780132546 @default.
• W2313644743 hasConcept C2780479503 @default.
• W2313644743 hasConcept C71924100 @default.
• W2313644743 hasConcept C87355193 @default.
• W2313644743 hasConcept C90924648 @default.
• W2313644743 hasConceptScore W2313644743C119060515 @default.
• W2313644743 hasConceptScore W2313644743C121332964 @default.
• W2313644743 hasConceptScore W2313644743C126322002 @default.
• W2313644743 hasConceptScore W2313644743C141071460 @default.
• W2313644743 hasConceptScore W2313644743C142424586 @default.
• W2313644743 hasConceptScore W2313644743C188816634 @default.
• W2313644743 hasConceptScore W2313644743C2777138892 @default.
• W2313644743 hasConceptScore W2313644743C2778260677 @default.
• W2313644743 hasConceptScore W2313644743C2779134260 @default.
• W2313644743 hasConceptScore W2313644743C2780132546 @default.
• W2313644743 hasConceptScore W2313644743C2780479503 @default.
• W2313644743 hasConceptScore W2313644743C71924100 @default.
• W2313644743 hasConceptScore W2313644743C87355193 @default.
• W2313644743 hasConceptScore W2313644743C90924648 @default.
• W2313644743 hasIssue "5" @default.
• W2313644743 hasLocation W23136447431 @default.
• W2313644743 hasLocation W23136447432 @default.
• W2313644743 hasLocation W23136447433 @default.
• W2313644743 hasOpenAccess W2313644743 @default.
• W2313644743 hasPrimaryLocation W23136447431 @default.

• next